Wolverine Asset Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Wolverine Asset Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23	Buy	+1,039	New	+$34	﹤0.01%	1669
2023 Q1	–	Sell	-10,646	Closed	-$319	–	1990
2022 Q4	$319	Hold	10,646	–	–	﹤0.01%	2015
2022 Q3	$0	Buy	10,646 +2,317	+28%	+$202	﹤0.01%	2440
2022 Q2	$0	Hold	8,329	–	–	﹤0.01%	2393
2022 Q1	$2K	Sell	8,329 -65	-0.8%	-$36	﹤0.01%	2083
2021 Q4	$12K	Buy	+8,394	New	+$11.7K	﹤0.01%	1818
2021 Q2	–	Sell	-60	Closed	–	–	2294
2021 Q1	$0	Buy	+60	New	+$88	﹤0.01%	2149
2020 Q3	–	Sell	-72,772	Closed	-$72K	–	1662
2020 Q2	$72K	Buy	72,772 +17,772	+32%	+$11.1K	﹤0.01%	1152
2020 Q1	$35K	Buy	+55,000	New	+$43.2K	﹤0.01%	1217

Other funds holding JSPRW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wolverine Asset Management's JSPRW Position: Q1 2026 in Review

Wolverine Asset Management opened a new position in Japer Therapeutics Warrants (JSPRW) in Q1 2026: 1,039 shares worth $23. The stake represents ﹤0.01% of the portfolio and ranks #1669 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in JSPRW as recently as Q4 2022.

Wolverine Asset Management first reported a position in JSPRW in Q1 2020 and has held it in 9 quarters since. The position peaked at $72K in Q2 2020. 7 funds tracked by Wall St. Rank hold JSPRW as of Q1 2026.

Wolverine Asset Management held 1,039 shares of Japer Therapeutics Warrants worth $23 as of Q1 2026.
Japer Therapeutics Warrants was a new Wolverine Asset Management position in Q1 2026.
Japer Therapeutics Warrants made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1669 holding.
Wolverine Asset Management first reported a position in Japer Therapeutics Warrants in Q1 2020 and has held it in 9 quarters since.
Wolverine Asset Management's Japer Therapeutics Warrants position peaked at $72K in Q2 2020.
7 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.